Emily G. Ashkani, Brian D. McKenna, Jennifer L. Bryant, Dilza Trevisan-Silva, Nicholas E. Sherman, Kimberly A. Chianese-Bullock, Craig L. Slingluff
{"title":"多肽疫苗在资源有限条件下的稳定性","authors":"Emily G. Ashkani, Brian D. McKenna, Jennifer L. Bryant, Dilza Trevisan-Silva, Nicholas E. Sherman, Kimberly A. Chianese-Bullock, Craig L. Slingluff","doi":"10.1007/s10989-024-10620-y","DOIUrl":null,"url":null,"abstract":"<p>We have previously shown that lyophilized mixtures of six- and twelve-melanoma peptide vaccines retain stability, purity, and amino acid sequence identity for up to five years when stored at -80 °C. However, this temperature requirement presents a significant obstacle to storage and distribution of vaccines for low-resource environments. Thus, we examined the stability of these peptides over a range of temperatures for varying durations of time. When stored at +4 °C or at room temperature for up to three months, 17 of the 18 peptides remained stable. The only change for the remaining peptide was an increase in an oxidized methionine residue. The results presented in this report support broadening the accessibility of these and other peptide-based vaccines to resources-limited communities.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Stability of Multi-Peptide Vaccines in Conditions Enabling Accessibility in Limited Resource Settings\",\"authors\":\"Emily G. Ashkani, Brian D. McKenna, Jennifer L. Bryant, Dilza Trevisan-Silva, Nicholas E. Sherman, Kimberly A. Chianese-Bullock, Craig L. Slingluff\",\"doi\":\"10.1007/s10989-024-10620-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>We have previously shown that lyophilized mixtures of six- and twelve-melanoma peptide vaccines retain stability, purity, and amino acid sequence identity for up to five years when stored at -80 °C. However, this temperature requirement presents a significant obstacle to storage and distribution of vaccines for low-resource environments. Thus, we examined the stability of these peptides over a range of temperatures for varying durations of time. When stored at +4 °C or at room temperature for up to three months, 17 of the 18 peptides remained stable. The only change for the remaining peptide was an increase in an oxidized methionine residue. The results presented in this report support broadening the accessibility of these and other peptide-based vaccines to resources-limited communities.</p>\",\"PeriodicalId\":2,\"journal\":{\"name\":\"ACS Applied Bio Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-06-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Bio Materials\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1007/s10989-024-10620-y\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1007/s10989-024-10620-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
摘要
我们以前的研究表明,冻干的六联和十二联黑色素瘤多肽疫苗混合物在-80 °C的条件下可保持稳定性、纯度和氨基酸序列一致性长达五年。然而,这一温度要求对低资源环境中疫苗的储存和分发构成了重大障碍。因此,我们研究了这些多肽在不同温度和不同时间范围内的稳定性。在 +4 °C 或室温下储存长达三个月时,18 种肽中有 17 种保持稳定。其余肽的唯一变化是氧化蛋氨酸残基的增加。本报告中介绍的结果支持将这些和其他基于多肽的疫苗推广到资源有限的社区。
Stability of Multi-Peptide Vaccines in Conditions Enabling Accessibility in Limited Resource Settings
We have previously shown that lyophilized mixtures of six- and twelve-melanoma peptide vaccines retain stability, purity, and amino acid sequence identity for up to five years when stored at -80 °C. However, this temperature requirement presents a significant obstacle to storage and distribution of vaccines for low-resource environments. Thus, we examined the stability of these peptides over a range of temperatures for varying durations of time. When stored at +4 °C or at room temperature for up to three months, 17 of the 18 peptides remained stable. The only change for the remaining peptide was an increase in an oxidized methionine residue. The results presented in this report support broadening the accessibility of these and other peptide-based vaccines to resources-limited communities.